2012
DOI: 10.5435/00124635-201209000-00001
|View full text |Cite
|
Sign up to set email alerts
|

Bone Morphogenetic Protein in Spine Surgery: Current and Future Uses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
43
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 72 publications
(46 citation statements)
references
References 30 publications
2
43
1
Order By: Relevance
“…The concerns put forward by authors like Dimar and Carragee have led others to avoid rhBMP-2 in patients with a history of cancer [35]. However, in our opinion the lack of strong evidence that correlates rhBMP-2 and cancer does not support denying rhBMP-2 to patients with a cancer history who may benefit from it.…”
Section: Discussioncontrasting
confidence: 41%
“…The concerns put forward by authors like Dimar and Carragee have led others to avoid rhBMP-2 in patients with a history of cancer [35]. However, in our opinion the lack of strong evidence that correlates rhBMP-2 and cancer does not support denying rhBMP-2 to patients with a cancer history who may benefit from it.…”
Section: Discussioncontrasting
confidence: 41%
“…17,18 Specifically, BMP-2, -4, -6, -7, -9 and -14 have been shown to have significant osteogenic properties. 19,20 BMP-2 and -7, additionally, have been demonstrated to directly promote local neovascularization. 7 Several unique properties of BMP-2 may account for its robust healing potential.…”
Section: Synthetic Bone Graftsmentioning
confidence: 99%
“…# -number of publications. BMP-8a) have a known osteochondral function (Even et al, 2012). BMP-2 specifically is a disulfide-linked homodimer with a known role in osteoblast differentiation.…”
Section: Erythropoietin) Fgf (Fibroblast Growth Factor) Ftir (Fourimentioning
confidence: 99%